|Application:||Gene expression microarray analysis|
|Number of samples:||8|
|Release date:||Nov 1 2016|
|Last update date:||Aug 9 2018|
|Diseases:||Lung Neoplasms, Neoplasms|
|Dataset link||Gene expression profiling of lung cancer cells following treatment with dasatinib|
A549 and H661 dasatinib-resistant lung cancer cells and H1666 and Cal12 dasatinib-sensitive cells were treated with vehicle (control) or 150 nM dasatinib for 72 h (8 samples). Total RNA was isolated and whole transcriptomes were profiled using the Human Gene U133A plus 2.0 platform from Affymetrix.